Finland· FI-REL-REL61406
Vesanoid
A tretinoin product containing tretinoin, registered in Finland by Orifarm Oy. The same ATC class is registered in 8 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Tretinoin is registered in 8 of 19 countries.
Countries holding a registration under ATC L01XF01 (tretinoin), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 4 of them publish a price we can compare per daily dose
Tretinoin · ATC L01XF01
8 / 19 countries
- Belgiumprice
- Canada
- Finlandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Switzerlandprice
The record
At a glance
Fimea (Finland)- Active substance
- Tretinoin
- Manufacturer
- Orifarm Oy
- Country
- Finland (FI)
- ATC code
- L01XF01
- ATC class
- Tretinoin
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 1
1 priced- fi_myyntilupa162279100EUR 512.37
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
366 interactions on record for tretinoin.
Graded by severity as the source publishes them — 29 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tretinoin · interactions on record
366 records
- 29 severe
- 101 moderate
- 17 minor
- 219 info
Most severe, free to view
- Aminocaproic acidB02AA01severe
- Tranexamic acidB02AA02severe
- AprotininB02AB01severe
- MipomersenC10AX11severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Tretinoin in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumVesanoid 10 mgCheplapharm Arzneimittel
- SpainVESANOID 10 mg CAPSULAS BLANDASCheplapharm Arzneimittel Gmbh
- FranceVESANOID 10 mg, capsule molleCHEPLAPHARM ARZNEIMITTEL (ALLEMAGNE)
- IrelandVesanoid 10 mg soft capsulesCheplapharm Arzneimittel GmbH
- NorwayVesanoidCheplapharm Arzneimittel GmbH
- PolandVesanoidCheplapharm Arzneimittel GmbH
- United StatesAltrenoBausch Health US, LLC
- United KingdomActicin 0.025% creamKyowa Kirin Ltd
Authorised across Europe · EMA
The same active substance is authorised in 14 EEA countries. Names it is sold under:
- Austria · Vesanoid
- Belgium · Vesanoid
- Germany · Cordes Vas, Vesanoid
- Spain · Neocare, Retirides
- France · Effederm, Ketrel
- United Kingdom (Northern Ireland) · Tretinoin Neon Healthcare, Vesanoid
- Croatia · Vesanoid
- Ireland · Vesanoid
- Italy · Tretinoina Same Savoma Medicinali, Vesanoid
- Malta · Ketrel
- Netherlands · Vesanoid
- Poland · Vesanoid
- Portugal · Ketrel, Vesanoid
- Slovakia · Vesanoid
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/454e1c26-cb1c-4a02-a7df-1f4cc6316e23 GET /v1/drugs/454e1c26-cb1c-4a02-a7df-1f4cc6316e23?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "kapseli, pehmeä",
"route": "Suun kautta",
"ddd_unit": null,
"strength": "10 mg",
"atc_label": "tretinoiini",
"ma_number": "42345",
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": null,
"fimea_rel_id": "REL61406",
"authorised_at": "2023-07-25"
}See everything about tretinoin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.